The DOI matches its Crossref record; 211 of the 211 references it cites were found in a registry or an index.
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
Open accessAbstract
Since the publication of the Revised European-American Classification of Lymphoid Neoplasms in 1994, subsequent updates of the classification of lymphoid neoplasms have been generated through iterative international efforts to achieve broad consensus among hematopathologists, geneticists, molecular scientists, and clinicians. Significant progress has recently been made in the characterization of malignancies of the immune system, with many new insights provided by genomic studies. They have led to this proposal. We have followed the same process that was successfully used for the third and fourth editions of the World Health Organization Classification of Hematologic Neoplasms. The definition, recommended studies, and criteria for the diagnosis of many entities have been extensively refined. Some categories considered provisional have now been upgraded to definite entities. Terminology for some diseases has been revised to adapt nomenclature to the current knowledge of their biology, but these modifications have been restricted to well-justified situations. Major findings from recent genomic studies have impacted the conceptual framework and diagnostic criteria for many disease entities. These changes will have an impact on optimal clinical management. The conclusions of this work are summarized in this report as the proposed International Consensus Classification of mature lymphoid, histiocytic, and dendritic cell tumors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gine, E., Martinez, A., Villamor, N., Lopez-Guillermo, A., Camos, M., Martinez, D., Esteve, J., Calvo, X., Muntanola, A., Abrisqueta, P., et al. (2010) · Haematologica · doi:10.3324/haematol.2010.022277 · Cited by 196
Self-citationRetractedWHO Classification of Tumours of Haematopoietic and Lymphoid Tissues
Swerdlow, S. H. (2017) · Medical Entomology and Zoology · Cited by 12,933
Self-citationThe 2016 revision of the World Health Organization classification of lymphoid neoplasms
Swerdlow, S. H., Campo, E., Pileri, S. A., Harris, N. L., Stein, H., Siebert, R., Advani, R., Ghielmini, M., Salles, G. A., Zelenetz, A. D., et al. (2016) · Blood · doi:10.1182/blood-2016-01-643569 · Cited by 7,831
Self-citationHarris, N., Jaffe, E., Stein, H., Banks, P., Chan, J., Cleary, M., Delsol, G., De Wolf- Peeters, C., Falini, B., & Gatter, K. (1994) · Blood · doi:10.1182/blood.v84.5.1361.1361 · Cited by 6,327
Self-citationInternational Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
Rajkumar, S. V., Dimopoulos, M. A., Palumbo, A., Blade, J., Merlini, G., Mateos, M.-V., Kumar, S., Hillengass, J., Kastritis, E., Richardson, P., et al. (2014) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70442-5 · Cited by 4,978
Self-citationRosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Self-citationWHO classification of haematolymphoid tumours
Gaillard, F., Weerakkody, Y., & Sharma, R. (2010) · Radiopaedia.org · doi:10.53347/rid-9250 · Cited by 3,776
Arber, D. A., Orazi, A., Hasserjian, R. P., Borowitz, M. J., Calvo, K. R., Kvasnicka, H.-M., Wang, S. A., Bagg, A., Barbui, T., Branford, S., et al. (2022) · Blood · doi:10.1182/blood.2022015850 · Cited by 2,945
Self-citationThe Non-Hodgkin's Lymphoma Classification Project (1997) · Blood · doi:10.1182/blood.v89.11.3909 · Cited by 2,461
Genetics and pathogenesis of diffuse large B-cell lymphoma
Schmitz, R., Wright, G. W., Huang, D. W., Johnson, C. A., Phelan, J. D., Wang, J. Q., Roulland, S., Kasbekar, M., Young, R. M., Shaffer, A. L., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1801445 · Cited by 2,241
Self-citationPalumbo, A., Avet-Loiseau, H., Oliva, S., Lokhorst, H. M., Goldschmidt, H., Rosinol, L., Richardson, P., Caltagirone, S., Lahuerta, J. J., Facon, T., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2015.61.2267 · Cited by 2,210
Self-citationCampo, E., Swerdlow, S. H., Harris, N. L., Pileri, S., Stein, H., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2011-01-293050 · Cited by 2,008
Self-citationChapuy, B., Stewart, C., Dunford, A. J., Kim, J., Kamburov, A., Redd, R. A., Lawrence, M. S., Roemer, M. G. M., Li, A. J., Ziepert, M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0016-8 · Cited by 1,941
Self-citationHallek, M., Cheson, B. D., Catovsky, D., Caligaris-Cappio, F., Dighiero, G., Döhner, H., Hillmen, P., Keating, M., Montserrat, E., Chiorazzi, N., et al. (2018) · Blood · doi:10.1182/blood-2017-09-806398 · Cited by 1,740
Self-citationThe 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas
Willemze, R., Cerroni, L., Kempf, W., Berti, E., Facchetti, F., Swerdlow, S. H., & Jaffe, E. S. (2019) · Blood · doi:10.1182/blood-2018-11-881268 · Cited by 1,412
Self-citationMYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
Treon, S. P., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Sheehy, P., Manning, R. J., Patterson, C. J., Tripsas, C., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200710 · Cited by 1,294
Self-citationWright, G. W., Huang, D. W., Phelan, J. D., Coulibaly, Z. A., Roulland, S., Young, R. M., Wang, J. Q., Schmitz, R., Morin, R. D., Tang, J., et al. (2020) · Cancer Cell · doi:10.1016/j.ccell.2020.03.015 · Cited by 1,169
Self-citationThe molecular classification of multiple myeloma
Zhan, F., Huang, Y., Colla, S., Stewart, J. P., Hanamura, I., Gupta, S., Epstein, J., Yaccoby, S., Sawyer, J., Burington, B., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013458 · Cited by 1,133
Mutations driving CLL and their evolution in progression and relapse
Landau, D. A., Tausch, E., Taylor-Weiner, A. N., Stewart, C., Reiter, J. G., Bahlo, J., Kluth, S., Bozic, I., Lawrence, M., Böttcher, S., et al. (2015) · Nature · doi:10.1038/nature15395 · Cited by 1,068
Wright, G., Tan, B., Rosenwald, A., Hurt, E. H., Wiestner, A., & Staudt, L. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732008100 · Cited by 1,040
Self-citationPathology and genetics: Tumours of haematopoietic and lymphoid tissues
Vyas, P. (2001) · The Lancet Oncology · Cited by 1,007
Sonneveld, P., Avet-Loiseau, H., Lonial, S., Usmani, S., Siegel, D., Anderson, K. C., Chng, W.-J., Moreau, P., Attal, M., Kyle, R. A., et al. (2016) · Blood · doi:10.1182/blood-2016-01-631200 · Cited by 928
Self-citationOwen, R. G., Treon, S. P., Al-Katib, A., Fonseca, R., Greipp, P. R., McMaster, M. L., Morra, E., Pangalis, G. A., San Miguel, J. F., Branagan, A. R., et al. (2003) · Seminars in Oncology · doi:10.1053/sonc.2003.50082 · Cited by 924
Self-citationInternational Myeloma Working Group molecular classification of multiple myeloma: spotlight review
Fonseca, R., Bergsagel, P. L., Drach, J., Shaughnessy, J., Gutierrez, N., Stewart, A. K., Morgan, G., Van Ness, B., Chesi, M., Minvielle, S., et al. (2009) · Leukemia · doi:10.1038/leu.2009.174 · Cited by 886
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Puente, X. S., Beà, S., Valdés-Mas, R., Villamor, N., Gutiérrez-Abril, J., Martín-Subero, J. I., Munar, M., Rubio-Pérez, C., Jares, P., Aymerich, M., et al. (2015) · Nature · doi:10.1038/nature14666 · Cited by 829
Self-citationde Leval, L., Rickman, D. S., Thielen, C., Reynies, A. D., Huang, Y.-L., Delsol, G., Lamant, L., Leroy, K., Brière, J., Molina, T., et al. (2007) · Blood · doi:10.1182/blood-2006-10-055145 · Cited by 631
Self-citationPastore, A., Jurinovic, V., Kridel, R., Hoster, E., Staiger, A. M., Szczepanowski, M., Pott, C., Kopp, N., Murakami, M., Horn, H., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00169-2 · Cited by 618
Self-citationYounes, A., Sehn, L. H., Johnson, P., Zinzani, P. L., Hong, X., Zhu, J., Patti, C., Belada, D., Samoilova, O., Suh, C., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.02403 · Cited by 608
Self-citationMorschhauser, F., Tilly, H., Chaidos, A., McKay, P., Phillips, T., Assouline, S., Batlevi, C. L., Campbell, P., Ribrag, V., Damaj, G. L., et al. (2020) · The Lancet Oncology · doi:10.1016/s1470-2045(20)30441-1 · Cited by 604
Self-citationDojcinov, S. D., Venkataraman, G., Raffeld, M., Pittaluga, S., & Jaffe, E. S. (2010) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e3181cf8622 · Cited by 571
Self-citationA monoclonal gammopathy precedes multiple myeloma in most patients
Weiss, B. M., Abadie, J., Verma, P., Howard, R. S., & Kuehl, W. M. (2009) · Blood · doi:10.1182/blood-2008-12-195008 · Cited by 569
Genomic complexity of multiple myeloma and its clinical implications
Manier, S., Salem, K. Z., Park, J., Landau, D. A., Getz, G., & Ghobrial, I. M. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.122 · Cited by 560
Self-citationMolecular Pathogenesis and a Consequent Classification of Multiple Myeloma
Bergsagel, P. L., & Kuehl, W. M. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.021 · Cited by 556
Iqbal, J., Wright, G., Wang, C., Rosenwald, A., Gascoyne, R. D., Weisenburger, D. D., Greiner, T. C., Smith, L., Guo, S., Wilcox, R. A., et al. (2014) · Blood · doi:10.1182/blood-2013-11-536359 · Cited by 552
Self-citationLacy, S. E., Barrans, S. L., Beer, P. A., Painter, D., Smith, A. G., Roman, E., Cooke, S. L., Ruiz, C., Glover, P., Van Hoppe, S. J. L., et al. (2020) · Blood · doi:10.1182/blood.2019003535 · Cited by 506
Hunter, Z. R., Xu, L., Yang, G., Zhou, Y., Liu, X., Cao, Y., Manning, R. J., Tripsas, C., Patterson, C. J., Sheehy, P., et al. (2014) · Blood · doi:10.1182/blood-2013-09-525808 · Cited by 488
Self-citationIdentification of novel mutational drivers reveals oncogene dependencies in multiple myeloma
Walker, B. A., Mavrommatis, K., Wardell, C. P., Ashby, T. C., Bauer, M., Davies, F. E., Rosenthal, A., Wang, H., Qu, P., Hoering, A., et al. (2018) · Blood · doi:10.1182/blood-2018-03-840132 · Cited by 475
Self-citationParrilla Castellar, E. R., Jaffe, E. S., Said, J. W., Swerdlow, S. H., Ketterling, R. P., Knudson, R. A., Sidhu, J. S., Hsi, E. D., Karikehalli, S., Jiang, L., et al. (2014) · Blood · doi:10.1182/blood-2014-04-571091 · Cited by 472
Self-citationKimura, H., Ito, Y., Kawabe, S., Gotoh, K., Takahashi, Y., Kojima, S., Naoe, T., Esaki, S., Kikuta, A., Sawada, A., et al. (2012) · Blood · doi:10.1182/blood-2011-10-381921 · Cited by 448
Self-citationBartlett, N. L., Wilson, W. H., Jung, S.-H., Hsi, E. D., Maurer, M. J., Pederson, L. D., Polley, M.-Y. C., Pitcher, B. N., Cheson, B. D., Kahl, B. S., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01994 · Cited by 434
Self-citationClemens, M. W., Medeiros, L. J., Butler, C. E., Hunt, K. K., Fanale, M. A., Horwitz, S., Weisenburger, D. D., Liu, J., Morgan, E. A., Kanagal-Shamanna, R., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.63.3412 · Cited by 422
Self-citationSpatial genomic heterogeneity in multiple myeloma revealed by multi-region sequencing
Rasche, L., Chavan, S. S., Stephens, O. W., Patel, P. H., Tytarenko, R., Ashby, C., Bauer, M., Stein, C., Deshpande, S., Wardell, C., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00296-y · Cited by 417
Ennishi, D., Jiang, A., Boyle, M., Collinge, B., Grande, B. M., Ben-Neriah, S., Rushton, C., Tang, J., Thomas, N., Slack, G. W., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01583 · Cited by 414
Self-citationEskelund, C. W., Dahl, C., Hansen, J. W., Westman, M., Kolstad, A., Pedersen, L. B., Montano-Almendras, C. P., Husby, S., Freiburghaus, C., Ek, S., et al. (2017) · Blood · doi:10.1182/blood-2017-04-779736 · Cited by 407
Efficacy of MEK inhibition in patients with histiocytic neoplasms
Diamond, E. L., Durham, B. H., Ulaner, G. A., Drill, E., Buthorn, J., Ki, M., Bitner, L., Cho, H., Young, R. J., Francis, J. H., et al. (2019) · Nature · doi:10.1038/s41586-019-1012-y · Cited by 395
Self-citationActivating mutations of STAT5B and STAT3 in lymphomas derived from γδ-T or NK cells
Küçük, C., Jiang, B., Hu, X., Zhang, W., Chan, J. K. C., Xiao, W., Lack, N., Alkan, C., Williams, J. C., Avery, K. N., et al. (2015) · Nature Communications · doi:10.1038/ncomms7025 · Cited by 393
Self-citationClassification of lymphoid neoplasms: the microscope as a tool for disease discovery
Jaffe, E. S., Harris, N. L., Stein, H., & Isaacson, P. G. (2008) · Blood · doi:10.1182/blood-2008-07-077982 · Cited by 382
Self-citationFu, K. (2005) · Blood · doi:10.1182/blood-2005-04-1753 · Cited by 346
Fan, Z., Natkunam, Y., Bair, E., Tibshirani, R., & Warnke, R. A. (2003) · The American Journal of Surgical Pathology · doi:10.1097/00000478-200310000-00007 · Cited by 344
Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia
Rossi, D., Khiabanian, H., Spina, V., Ciardullo, C., Bruscaggin, A., Famà, R., Rasi, S., Monti, S., Deambrogi, C., De Paoli, L., et al. (2014) · Blood · doi:10.1182/blood-2013-11-539726 · Cited by 338
Nadeu, F., Delgado, J., Royo, C., Baumann, T., Stankovic, T., Pinyol, M., Jares, P., Navarro, A., Martín-García, D., Beà, S., et al. (2016) · Blood · doi:10.1182/blood-2015-07-659144 · Cited by 336
Self-citationCaers, J., Paiva, B., Zamagni, E., Leleu, X., Bladé, J., Kristinsson, S. Y., Touzeau, C., Abildgaard, N., Terpos, E., Heusschen, R., et al. (2018) · Journal of Hematology & Oncology · doi:10.1186/s13045-017-0549-1 · Cited by 336
Vallois, D., Dobay, M. P. D., Morin, R. D., Lemonnier, F., Missiaglia, E., Juilland, M., Iwaszkiewicz, J., Fataccioli, V., Bisig, B., Roberti, A., et al. (2016) · Blood · doi:10.1182/blood-2016-02-698977 · Cited by 324
Self-citationOrchard, J. A., Garand, R., Davis, Z. A., Babbage, G., Sahota, S. S., Matutes, E., Catovsky, D., Thomas, P., Avet‐Loiseau, H., & Oscier, D. G. (2003) · Blood · doi:10.1182/blood-2002-06-1864 · Cited by 320
Effect of ibrutinib with R-CHOP chemotherapy in genetic subtypes of DLBCL
Wilson, W. H., Wright, G. W., Huang, D. W., Hodkinson, B., Balasubramanian, S., Fan, Y., Vermeulen, J., Shreeve, M., & Staudt, L. M. (2021) · Cancer Cell · doi:10.1016/j.ccell.2021.10.006 · Cited by 315
Self-citationDojcinov, S. D., Venkataraman, G., Pittaluga, S., Wlodarska, I., Schrager, J. A., Raffeld, M., Hills, R. K., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2010-12-323238 · Cited by 314
Self-citationSha, C., Barrans, S., Cucco, F., Bentley, M. A., Care, M. A., Cummin, T., Kennedy, H., Thompson, J. S., Uddin, R., Worrillow, L., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.18.01314 · Cited by 300
Self-citationMonoclonal gammopathy of clinical significance: a novel concept with therapeutic implications
Fermand, J.-P., Bridoux, F., Dispenzieri, A., Jaccard, A., Kyle, R. A., Leung, N., & Merlini, G. (2018) · Blood · doi:10.1182/blood-2018-04-839480 · Cited by 299
International Myeloma Working Group risk stratification model for smoldering multiple myeloma (SMM)
Mateos, M.-V., Kumar, S., Dimopoulos, M. A., González-Calle, V., Kastritis, E., Hajek, R., De Larrea, C. F., Morgan, G. J., Merlini, G., Goldschmidt, H., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-00366-3 · Cited by 291
Self-citationNicolae, A., Pittaluga, S., Abdullah, S., Steinberg, S. M., Pham, T. A., Davies-Hill, T., Xi, L., Raffeld, M., & Jaffe, E. S. (2015) · Blood · doi:10.1182/blood-2015-02-630632 · Cited by 282
Self-citationGenetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma
Heavican, T. B., Bouska, A., Yu, J., Lone, W., Amador, C., Gong, Q., Zhang, W., Li, Y., Dave, B. J., Nairismägi, M.-L., et al. (2019) · Blood · doi:10.1182/blood-2018-09-872549 · Cited by 275
Self-citationNowakowski, G. S., Chiappella, A., Gascoyne, R. D., Scott, D. W., Zhang, Q., Jurczak, W., Özcan, M., Hong, X., Zhu, J., Jin, J., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01366 · Cited by 275
Self-citationDavies, A., Cummin, T. E., Barrans, S., Maishman, T., Mamot, C., Novak, U., Caddy, J., Stanton, L., Kazmi-Stokes, S., McMillan, A., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30935-5 · Cited by 273
Self-citationJiménez, C., Sebastián, E., Chillón, C., Giraldo, P., Hernández, J. M., Escalante, F., González‐López, T. J., Aguilera, C., de Coca, A. G., Murillo, I., et al. (2013) · Leukemia · doi:10.1038/leu.2013.62 · Cited by 267
Single cell dissection of plasma cell heterogeneity in symptomatic and asymptomatic myeloma
Ledergor, G., Weiner, A., Zada, M., Wang, S.-Y., Cohen, Y. C., Gatt, M. E., Snir, N., Magen, H., Koren-Michowitz, M., Herzog-Tzarfati, K., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0269-2 · Cited by 263
Self-citationNavarro, A., Clot, G., Royo, C., Jares, P., Hadzidimitriou, A., Agathangelidis, A., Bikos, V., Darzentas, N., Papadaki, T., Salaverria, I., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-12-1615 · Cited by 256
Self-citationCopie-Bergman, C., Cuillière-Dartigues, P., Baia, M., Briere, J., Delarue, R., Canioni, D., Salles, G., Parrens, M., Belhadj, K., Fabiani, B., et al. (2015) · Blood · doi:10.1182/blood-2015-05-647602 · Cited by 255
Self-citationPiccaluga, P. P., Agostinelli, C., Califano, A., Carbone, A., Fantoni, L., Ferrari, S., Gazzola, A., Gloghini, A., Righi, S., Rossi, M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1708 · Cited by 249
Self-citationSimonelli, C., Spina, M., Cinelli, R., Talamini, R., Tedeschi, R., Gloghini, A., Vaccher, E., Carbone, A., & Tirelli, U. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.013 · Cited by 246
Baliakas, P., Jeromin, S., Iskas, M., Puiggros, A., Plevova, K., Nguyen-Khac, F., Davis, Z., Rigolin, G. M., Visentin, A., Xochelli, A., et al. (2019) · Blood · doi:10.1182/blood-2018-09-873083 · Cited by 242
Self-citationCerroni, L., Signoretti, S., Höfler, G., Annessi, G., Pütz, B., Lackinger, E., Metze, D., Giannetti, A., & Kerl, H. (1997) · The American Journal of Surgical Pathology · doi:10.1097/00000478-199711000-00005 · Cited by 239
Self-citationDefective Epstein–Barr virus in chronic active infection and haematological malignancy
Okuno, Y., Murata, T., Sato, Y., Muramatsu, H., Ito, Y., Watanabe, T., Okuno, T., Murakami, N., Yoshida, K., Sawada, A., et al. (2019) · Nature Microbiology · doi:10.1038/s41564-018-0334-0 · Cited by 239
Self-citationEvolutionary biology of high-risk multiple myeloma
Pawlyn, C., & Morgan, G. J. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.63 · Cited by 238
Dobay, M. P., Lemonnier, F., Missiaglia, E., Bastard, C., Vallois, D., Jais, J.-P., Scourzic, L., Dupuy, A., Fataccioli, V., Pujals, A., et al. (2017) · Haematologica · doi:10.3324/haematol.2016.158428 · Cited by 231
Self-citationRecurrent mutations of CD79B and MYD88 are the hallmark of primary central nervous system lymphomas
Nakamura, T., Tateishi, K., Niwa, T., Matsushita, Y., Tamura, K., Kinoshita, M., Tanaka, K., Fukushima, S., Takami, H., Arita, H., et al. (2016) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12259 · Cited by 227
Staiger, A. M., Ziepert, M., Horn, H., Scott, D. W., Barth, T. F. E., Bernd, H.-W., Feller, A. C., Klapper, W., Szczepanowski, M., Hummel, M., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.3660 · Cited by 221
Self-citationGayden, T., Sepulveda, F. E., Khuong-Quang, D.-A., Pratt, J., Valera, E. T., Garrigue, A., Kelso, S., Sicheri, F., Mikael, L. G., Hamel, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0251-4 · Cited by 220
Self-citationLaurent, C., Delas, A., Gaulard, P., Haioun, C., Moreau, A., Xerri, L., Traverse-Glehen, A., Rousset, T., Quintin-Roue, I., Petrella, T., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdv575 · Cited by 215
Self-citationNadeu, F., Martin-Garcia, D., Clot, G., Díaz-Navarro, A., Duran-Ferrer, M., Navarro, A., Vilarrasa-Blasi, R., Kulis, M., Royo, R., Gutiérrez-Abril, J., et al. (2020) · Blood · doi:10.1182/blood.2020005289 · Cited by 210
Self-citationMonoclonal Gammopathy of Renal Significance
Leung, N., Bridoux, F., & Nasr, S. H. (2021) · New England Journal of Medicine · doi:10.1056/nejmra1810907 · Cited by 210
CCND2 rearrangements are the most frequent genetic events in cyclin D1− mantle cell lymphoma
Salaverria, I., Royo, C., Carvajal-Cuenca, A., Clot, G., Navarro, A., Valera, A., Song, J. Y., Woroniecka, R., Rymkiewicz, G., Klapper, W., et al. (2013) · Blood · doi:10.1182/blood-2012-08-452284 · Cited by 201
Self-citationIndolent T-cell lymphoproliferative disease of the gastrointestinal tract
Perry, A. M., Warnke, R. A., Hu, Q., Gaulard, P., Copie-Bergman, C., Alkan, S., Wang, H.-Y., Cheng, J. X., Bacon, C. M., Delabie, J., et al. (2013) · Blood · doi:10.1182/blood-2013-07-512830 · Cited by 198
Self-citationChan, J. K. C., Chan, A. C. L., Cheuk, W., Wan, S.-K., Lee, W.-K., Lui, Y.-H., & Chan, W.-K. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318222dfcd · Cited by 195
Self-citationThe reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia
Beekman, R., Chapaprieta, V., Russiñol, N., Vilarrasa-Blasi, R., Verdaguer-Dot, N., Martens, J. H. A., Duran-Ferrer, M., Kulis, M., Serra, F., Javierre, B. M., et al. (2018) · Nature Medicine · doi:10.1038/s41591-018-0028-4 · Cited by 195
Self-citationLemonnier, F., Dupuis, J., Sujobert, P., Tournillhac, O., Cheminant, M., Sarkozy, C., Pelletier, L., Marçais, A., Robe, C., Fataccioli, V., et al. (2018) · Blood · doi:10.1182/blood-2018-04-840538 · Cited by 195
Self-citationHartmann, S., Eichenauer, D. A., Plütschow, A., Mottok, A., Bob, R., Koch, K., Bernd, H.-W., Cogliatti, S., Hummel, M., Feller, A. C., et al. (2013) · Blood · doi:10.1182/blood-2013-07-515825 · Cited by 192
Roberti, A., Dobay, M. P., Bisig, B., Vallois, D., Boéchat, C., Lanitis, E., Bouchindhomme, B., Parrens, M. C., Bossard, C., Quintanilla-Martinez, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12602 · Cited by 188
Self-citationLeonard, J. P., Kolibaba, K. S., Reeves, J. A., Tulpule, A., Flinn, I. W., Kolevska, T., Robles, R., Flowers, C. R., Collins, R., DiBella, N. J., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2017.73.2784 · Cited by 186
Self-citationMansoor, A., Pittaluga, S., Beck, P. L., Wilson, W. H., Ferry, J. A., & Jaffe, E. S. (2011) · Blood · doi:10.1182/blood-2010-08-302737 · Cited by 179
Self-citationClipson, A., Wang, M., de Leval, L., Ashton-Key, M., Wotherspoon, A., Vassiliou, G., Bolli, N., Grove, C., Moody, S., Escudero-Ibarz, L., et al. (2015) · Leukemia · doi:10.1038/leu.2014.330 · Cited by 176
Self-citationEnteropathy-associated T cell lymphoma subtypes are characterized by loss of function of SETD2
Moffitt, A. B., Ondrejka, S. L., McKinney, M., Rempel, R. E., Goodlad, J. R., Teh, C. H., Leppa, S., Mannisto, S., Kovanen, P. E., Tse, E., et al. (2017) · Journal of Experimental Medicine · doi:10.1084/jem.20160894 · Cited by 175
Self-citationAmador, C., Greiner, T. C., Heavican, T. B., Smith, L. M., Galvis, K. T., Lone, W., Bouska, A., D’Amore, F., Pedersen, M. B., Pileri, S., et al. (2019) · Blood · doi:10.1182/blood.2019000779 · Cited by 175
Self-citationPillai, R. K., Sathanoori, M., Van Oss, S. B., & Swerdlow, S. H. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826cebad · Cited by 173
Self-citationQuintanilla-Martinez, L., Ridaura, C., Nagl, F., Sáez-de-Ocariz, M., Durán-McKinster, C., Ruiz-Maldonado, R., Alderete, G., Grube, P., Lome-Maldonado, C., Bonzheim, I., et al. (2013) · Blood · doi:10.1182/blood-2013-05-502203 · Cited by 172
Self-citationLiu, Q., Salaverria, I., Pittaluga, S., Jegalian, A. G., Xi, L., Siebert, R., Raffeld, M., Hewitt, S. M., & Jaffe, E. S. (2013) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31826b9b57 · Cited by 167
Self-citationKemps, P. G., Picarsic, J., Durham, B. H., Hélias-Rodzewicz, Z., Hiemcke-Jiwa, L., van den Bos, C., van de Wetering, M. D., van Noesel, C. J. M., van Laar, J. A. M., Verdijk, R. M., et al. (2022) · Blood · doi:10.1182/blood.2021013338 · Cited by 163
Self-citationAttygalle, A. D., Cabeçadas, J., Gaulard, P., Jaffe, E. S., de Jong, D., Ko, Y. H., Said, J., & Klapper, W. (2014) · Histopathology · doi:10.1111/his.12251 · Cited by 162
Self-citationEmile, J., Aubart, F. C., Collin, M. P., Fraitag, S., Idbaïh, A., Abdel-Wahab, O. I., Rollins, B. J., Donadieu, J., & Haroche, J. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00311-1 · Cited by 161
Antigen receptor stereotypy in chronic lymphocytic leukemia
Σταματόπουλος, Κ., Agathangelidis, A., Rosenquist, R., & Ghia, P. (2016) · Leukemia · doi:10.1038/leu.2016.322 · Cited by 160
Self-citationLouissaint, A., Schafernak, K. T., Geyer, J. T., Kovach, A. E., Ghandi, M., Gratzinger, D., Roth, C. G., Paxton, C. N., Kim, S., Namgyal, C., et al. (2016) · Blood · doi:10.1182/blood-2015-12-682591 · Cited by 158
ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy
Chan, J. K. C., Lamant, L., Algar, E. M., Delsol, G., Tsang, W. Y. W., Lee, K. C., Tiedemann, K., & Chow, C. W. (2008) · Blood · doi:10.1182/blood-2008-03-147017 · Cited by 155
Mahmood, S., Bridoux, F., Venner, C. P., Sachchithanantham, S., Gilbertson, J. A., Rowczenio, D. M., Wagner, T., Sayed, R. H., Patel, K., Fontana, M., et al. (2015) · The Lancet Haematology · doi:10.1016/s2352-3026(15)00068-x · Cited by 151
Primary Immunodeficiencies Associated with EBV Disease
Cohen, J. I. (2015) · Current topics in microbiology and immunology · doi:10.1007/978-3-319-22822-8_10 · Cited by 151
Self-citationPedersen, M. B., Hamilton-Dutoit, S. J., Bendix, K., Ketterling, R. P., Bedroske, P. P., Luoma, I. M., Sattler, C. A., Boddicker, R. L., Bennani, N. N., Nørgaard, P. H., et al. (2017) · Blood · doi:10.1182/blood-2016-12-755496 · Cited by 148
Self-citationViral, immunologic, and clinical features of primary effusion lymphoma
Lurain, K. A., Polizzotto, M. N., Aleman, K. O., Bhutani, M., Wyvill, K. M., Goncalves, P. H., Ramaswami, R., Marshall, V. A., Miley, W., Steinberg, S. M., et al. (2019) · Blood · doi:10.1182/blood-2019-01-893339 · Cited by 146
Self-citationSchmidt, J., Gong, S., Marafioti, T., Mankel, B., González‐Farré, B., Balagué, O., Mozos, A., Cabeçadas, J., van der Walt, J. D., Hoehn, D., et al. (2016) · Blood · doi:10.1182/blood-2016-03-703819 · Cited by 144
Self-citationLaurent, C., Nicolae, A., Laurent, C., Bras, F. L., Haïoun, C., Fataccioli, V., Amara, N., Adélaïde, J., Guillé, A., Schiano, J.-M., et al. (2019) · Blood · doi:10.1182/blood.2019001904 · Cited by 141
Self-citationChang, K. T. E., Tay, A. Z. E., Kuick, C. H., et al. (2018) · Modern Pathology · doi:10.1038/s41379-018-0168-6 · Cited by 139
Pham‐Ledard, A., Beylot-Barry, M., Barbe, C., Leduc, M., Petrella, T., Vergier, B., Martínez, F., Cappellen, D., Merlio, J., & Grange, F. (2014) · JAMA Dermatology · doi:10.1001/jamadermatol.2014.821 · Cited by 136
A prospective study of mediastinal gray-zone lymphoma
Wilson, W. H., Pittaluga, S., Nicolae, A., Camphausen, K. A., Shovlin, M., Steinberg, S. M., Roschewski, M. J., Staudt, L. M., Jaffe, E. S., & Dunleavy, K. M. (2014) · Blood · doi:10.1182/blood-2014-03-564906 · Cited by 133
Self-citationPathobiology and treatment of lymphomatoid granulomatosis, a rare EBV-driven disorder
Melani, C. J., Jaffe, E. S., & Wilson, W. H. (2020) · Blood · doi:10.1182/blood.2019000933 · Cited by 131
Self-citationNg, S., Chung, T., Kato, S. X., Nakamura, S., Takahashi, E., Ko, Y. H., Khoury, J. D., Yin, C. C., Soong, R., Jeyasekharan, A. D. D., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.180430 · Cited by 130
Self-citationTranslocations targeting CCND2, CCND3, and MYCN do occur in t(11;14)-negative mantle cell lymphomas
Włodarska, I., Dierickx, D., Vanhentenrijk, V., Roosbroeck, K. V., Pospíšilová, H., Minnei, F., Verhoef, G. E. G., Thomas, J., Vandenberghe, P., & Wolf‐Peeters, C. D. (2008) · Blood · doi:10.1182/blood-2007-10-118794 · Cited by 129
Distinct molecular profile of IRF4-rearranged large B-cell lymphoma
Ramis-Zaldivar, J. E., González‐Farré, B., Balagué, O., Celis, V., Nadeu, F., Salmerón‐Villalobos, J., Andrés, M., Martín‐Guerrero, I., Garrido‐Pontnou, M., Gaafar, A., et al. (2019) · Blood · doi:10.1182/blood.2019002699 · Cited by 126
Self-citationKSHV/HHV8-mediated hematologic diseases
Cesarman, E., Chadburn, A., & Rubinstein, P. G. (2021) · Blood · doi:10.1182/blood.2020005470 · Cited by 124
Luchtel, R. A., Dasari, S., Oishi, N., Pedersen, M. B., Hu, G., Rech, K. L., Ketterling, R. P., Sidhu, J. S., Wang, X., Katoh, R., et al. (2018) · Blood · doi:10.1182/blood-2018-03-838524 · Cited by 123
Self-citationMorphologic Features of ALK-negative Anaplastic Large Cell Lymphomas With DUSP22 Rearrangements
King, R. L., Dao, L. N., McPhail, E. D., Jaffe, E. S., SAID, J. W., Swerdlow, S. H., Sattler, C. A., Ketterling, R. P., Sidhu, J. S., Hsi, E. D., et al. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000500 · Cited by 122
Self-citationHow I treat T-cell chronic active Epstein-Barr virus disease
Bollard, C. M., & Cohen, J. I. (2018) · Blood · doi:10.1182/blood-2018-03-785931 · Cited by 121
Self-citationMolecular profiling in diffuse large B‐cell lymphoma: why so many types of subtypes?
Morin, R. D., Arthur, S. E., & Hodson, D. J. (2021) · British Journal of Haematology · doi:10.1111/bjh.17811 · Cited by 121
Kraan, W., van Keimpema, M., Horlings, H. M., Schilder-Tol, E. J. M., Oud, M. E. C. M., Noorduyn, L. A., Kluin, P. M., Kersten, M. J., Spaargaren, M., & Pals, S. T. (2013) · Leukemia · doi:10.1038/leu.2013.348 · Cited by 120
KSHV/HHV8-negative Effusion-based Lymphoma, a Distinct Entity Associated With Fluid Overload States
Alexanian, S., SAID, J. W., Lones, M. A., & Pullarkat, S. T. (2013) · The American Journal of Surgical Pathology · doi:10.1097/pas.0b013e318267fabc · Cited by 119
Identification of diverse activating mutations of the RAS-MAPK pathway in histiocytic sarcoma
Shanmugam, V., Griffin, G. K., Jacobsen, E. D., Fletcher, C. D. �., Sholl, L. M., & Hornick, J. L. (2019) · Modern Pathology · doi:10.1038/s41379-018-0200-x · Cited by 119
Follicular lymphoma t(14;18)-negative is genetically a heterogeneous disease
Nann, D., Ramis-Zaldivar, J. E., Müller, I., González‐Farré, B., Schmidt, J., Egan, C., Salmerón‐Villalobos, J., Clot, G., Mattern, S., Otto, F., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002944 · Cited by 118
Self-citationYe, Q., Xu-Monette, Z. Y., Tzankov, A., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.6262 · Cited by 116
Cucco, F., Barrans, S., Sha, C., Clipson, A., Crouch, S., Dobson, R. C., Chen, Z., Thompson, J. S., Care, M. A., Cummin, T., et al. (2019) · Leukemia · doi:10.1038/s41375-019-0691-6 · Cited by 116
Self-citationOncogenetic landscape of lymphomagenesis in coeliac disease
Cording, S., Lhermitte, L., Malamut, G., Berrabah, S., Trinquand, A., Guégan, N., Villarèse, P., Kaltenbach, S., Meresse, B., Khater, S., et al. (2021) · Gut · doi:10.1136/gutjnl-2020-322935 · Cited by 113
Self-citationMutational landscape of gray zone lymphoma
Sarkozy, C., Hung, S. S., Chavez, E. A., Duns, G., Takata, K., Chong, L. C., Aoki, T., Jiang, A., Miyata‐Takata, T., Telenius, A., et al. (2020) · Blood · doi:10.1182/blood.2020007507 · Cited by 112
Self-citationCCND2 and CCND3 hijack immunoglobulin light-chain enhancers in cyclin D1− mantle cell lymphoma
Martin‐García, D., Navarro, A., Valdés‐Mas, R., Clot, G., Gutiérrez‐Abril, J., Prieto, M., Ribera‐Cortada, I., Woroniecka, R., Rymkiewicz, G., Bens, S., et al. (2018) · Blood · doi:10.1182/blood-2018-07-862151 · Cited by 111
Self-citationNowakowski, G. S., Hong, F., Scott, D. W., et al. (2021) · Journal of Clinical Oncology · doi:10.1200/jco.20.01375 · Cited by 110
Self-citationClot, G., Jares, P., Giné, E., Navarro, A., Royo, C., Pinyol, M., Martin‐García, D., Demajo, S., Espinet, B., Salar, A., et al. (2018) · Blood · doi:10.1182/blood-2018-03-838136 · Cited by 109
Self-citationGenomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade
Chapuy, B., Stewart, C., Dunford, A. J., Kim, J., Wienand, K., Kamburov, A., Griffin, G. K., Chen, P.-H., Lako, A., Redd, R. A., et al. (2019) · Blood · doi:10.1182/blood.2019002067 · Cited by 109
Self-citationvan Maldegem, F., van Dijk, R., Wormhoudt, T. A. M., Kluin, P. M., Willemze, R., Cerroni, L., van Noesel, C. J. M., & Bende, R. J. (2008) · Blood · doi:10.1182/blood-2008-01-132415 · Cited by 108
Self-citationFrequent germline mutations of HAVCR2 in sporadic subcutaneous panniculitis-like T-cell lymphoma
Polprasert, C., Takeuchi, Y., Kakiuchi, N., Yoshida, K., Assanasen, T., Sitthi, W., Bunworasate, U., Pirunsarn, A., Wudhikarn, K., Lawasut, P., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018028340 · Cited by 108
Ghione, P., Faruque, P. R., Mehta–Shah, N., Seshan, V., Özkaya, N., Bhaskar, S., Yeung, J., Spinner, M. A., Lunning, M. A., Inghirami, G. G., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020002396 · Cited by 108
Self-citationTreon, S. P., Gustine, J. N., Xu, L., Manning, R. J., Tsakmaklis, N., Demos, M. G., Meid, K., Guerrera, M. L., Munshi, M. N., Chan, G., et al. (2017) · British Journal of Haematology · doi:10.1111/bjh.15049 · Cited by 107
Self-citationGenomic profiling of primary histiocytic sarcoma reveals two molecular subgroups
Egan, C., Nicolae, A., Lack, J., Chung, H., Skarshaug, S., Pham, T., Navarro, W., Abdullaev, Z., Aguilera, N. S. I., Xi, L., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.230375 · Cited by 105
Self-citationWagener, R., Seufert, J., Raimondi, F., Bens, S., Kleinheinz, K., Nagel, I., Altmüller, J., Thiele, H., Hübschmann, D., Kohler, C. W., et al. (2018) · Blood · doi:10.1182/blood-2018-07-864025 · Cited by 104
Self-citationPaiva, B., Chandía, M., Vídriales, M., Colado, E., Caballero‐Velázquez, T., Escalante, F., de Coca, A. G., Montes, M.-C., García‐Sánz, R., Ocio, E. M., et al. (2014) · Blood · doi:10.1182/blood-2014-04-567909 · Cited by 103
Self-citationSharma, A., Oishi, N., Boddicker, R. L., Hu, G., Benson, H. K., Ketterling, R. P., Greipp, P. T., Knutson, D. L., Kloft‐Nelson, S. M., He, R. L., et al. (2018) · Blood · doi:10.1182/blood-2018-01-830968 · Cited by 102
Self-citationGenetic and phenotypic attributes of splenic marginal zone lymphoma
Bonfiglio, F., Bruscaggin, A., Guidetti, F., di Bergamo, L. T., Faderl, M., Spina, V., Condoluci, A., Bonomini, L., Forestieri, G., Koch, R., et al. (2021) · Blood · doi:10.1182/blood.2021012386 · Cited by 102
Self-citationEBV-Positive B-Cell Proliferations of Varied Malignant Potential
Natkunam, Y., Goodlad, J. R., Chadburn, A., de Jong, D., Gratzinger, D. A., Chan, J. K. C., SAID, J. W., & Jaffe, E. S. (2017) · American Journal of Clinical Pathology · doi:10.1093/ajcp/aqw214 · Cited by 101
Self-citationInsights into the genomic landscape of MYD88 wild-type Waldenström macroglobulinemia
Hunter, Z. R., Xu, L., Tsakmaklis, N., Demos, M. G., Kofides, A., Jiménez, C., Chan, G., Chen, J. G., Liu, X., Munshi, M. N., et al. (2018) · Blood Advances · doi:10.1182/bloodadvances.2018022962 · Cited by 101
Self-citationCXCR4 in Waldenström’s Macroglobulinema: chances and challenges
Kaiser, L., Hunter, Z. R., Treon, S. P., & Buske, C. (2020) · Leukemia · doi:10.1038/s41375-020-01102-3 · Cited by 101
Self-citationJaffe, E. S., Ashar, B. S., Clemens, M. W., Feldman, A. L., Gaulard, P., Miranda, R. N., Sohani, A. R., Stenzel, T. T., & Yoon, S. W. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.02778 · Cited by 99
Self-citationQuintanilla‐Martínez, L., Sander, B., Chan, J. K. C., Xerri, L., Ott, G., Campo, E., & Swerdlow, S. H. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1855-z · Cited by 98
Self-citationNadeu, F., Royo, R., Clot, G., Duran‐Ferrer, M., Navarro, A., Martín, S., Lu, J., Zenz, T., Baumann, T., Jares, P., et al. (2020) · Blood · doi:10.1182/blood.2020008311 · Cited by 97
Self-citationXu-Monette, Z. Y., Tu, M., Jabbar, K. J., Cao, X., Tzankov, A., Visco, C., Cai, Q., Montes‐Moreno, S., An, Y., Dybkær, K., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3479 · Cited by 96
Self-citationPresentation and Outcomes of Localized Immunoglobulin Light Chain Amyloidosis
Kourelis, T., Kyle, R. A., Dingli, D., Buadi, F. K., Kumar, S. K., Gertz, M. A., Lacy, M. Q., Kapoor, P., Go, R. S., Gonsalves, W. I., et al. (2017) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2017.02.016 · Cited by 96
Self-citationMaity, P. C., Bilal, M., Koning, M. T., Young, M., van Bergen, C. A. M., Renna, V., Nicolò, A., Datta, M., Gentner, E., Barendse, R. S., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1913810117 · Cited by 95
Self-citationReassessment of small lymphocytic lymphoma in the era of monoclonal B-cell lymphocytosis
Gibson, S. E., Swerdlow, S. H., Ferry, J. A., Surti, U., Cin, P. D., Harris, N. L., & Hasserjian, R. P. (2011) · Haematologica · doi:10.3324/haematol.2011.042333 · Cited by 94
Self-citationShimada, K., Yoshida, K., Suzuki, Y., Iriyama, C., Inoue, Y., Sanada, M., Kataoka, K., Yuge, M., Takagi, Y., Kusumoto, S., et al. (2020) · Blood · doi:10.1182/blood.2020007245 · Cited by 91
Self-citationWai, C. M. M., Chen, S., Phyu, T., Fan, S., Leong, S. M., Zheng, W., Low, L. C. Y., Choo, S., Lee, C.-K., Chung, T., et al. (2022) · Haematologica · doi:10.3324/haematol.2021.280003 · Cited by 87
Self-citationSchmidt, J., Ramis-Zaldivar, J. E., Nadeu, F., González‐Farré, B., Navarro, A., Egan, C., Montes-Mojarro, I. A., Marafioti, T., Cabeçadas, J., van der Walt, J. D., et al. (2017) · Blood · doi:10.1182/blood-2017-03-776278 · Cited by 86
Self-citationNahi, H., Genell, A., Wålinder, G., Uttervall, K., Juliusson, G., Karin, F., Hansson, M., Svensson, R., Linder, O., Carlson, K. E., et al. (2017) · European Journal Of Haematology · doi:10.1111/ejh.12907 · Cited by 83
Observation as the initial management strategy in patients with mantle cell lymphoma
Abrisqueta, P., Scott, D. W., Slack, G. W., Steidl, C., Mottok, A., Gascoyne, R. D., Connors, J. M., Sehn, L. H., Savage, K. J. J., Gerrie, A. S., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx333 · Cited by 83
Self-citationSoderquist, C. R., Patel, N., Murty, V. V. V. S., Betman, S., Aggarwal, N., Young, K. H., Xerri, L., Leeman‐Neill, R. J., Lewis, S. K., Green, P. H., et al. (2019) · Haematologica · doi:10.3324/haematol.2019.230961 · Cited by 81
Self-citationVeloza, L. C., Cavalieri, D., Missiaglia, E., Ledoux‐Pilon, A., Bisig, B., Pereira, B., Bonnet, C. M., Poullot, E., Quintanilla‐Martínez, L., Dubois, R., et al. (2022) · Haematologica · doi:10.3324/haematol.2022.281226 · Cited by 81
Self-citationSiddiqi, I. N., Friedman, J., Barry-Holson, K. Q., Ma, C., Thodima, V. J., Kang, I. M., Padmanabhan, R., Dias, L. M., Kelly, K. R., Brynes, R. K., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.51 · Cited by 80
Mantle cell lymphoma—a spectrum from indolent to aggressive disease
Sander, B., Quintanilla‐Martínez, L., Ott, G., et al. (2015) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-015-1840-6 · Cited by 77
Self-citationBeltzung, F., Ortonne, N., Pelletier, L., Beylot-Barry, M., Oro, S., Franck, F., Pereira, B., Godfraind, C., Delfau‐Larue, M., D'Incan, M., et al. (2020) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001470 · Cited by 76
McPhail, E. D., Maurer, M. J., Macon, W. R., Feldman, A. L., Kurtin, P. J., Ketterling, R. P., Vaidya, R., Cerhan, J. R., Ansell, S. M., Porrata, L. F., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.190157 · Cited by 75
Self-citationGenetic and epigenetic insights into cutaneous T-cell lymphoma
Tensen, C. P., Quint, K. D., & Vermeer, M. H. (2021) · Blood · doi:10.1182/blood.2019004256 · Cited by 75
The pathological features of angioimmunoblastic T-cell lymphomas with IDH2 mutations
Steinhilber, J., Mederake, M., Bonzheim, I., Serinsöz-Linke, E., Müller, I., Fallier‐Becker, P., Lemonnier, F., Gaulard, P., Fend, F., & Quintanilla‐Martínez, L. (2019) · Modern Pathology · doi:10.1038/s41379-019-0254-4 · Cited by 74
Self-citationKato, S. X., Asano, N., Miyata‐Takata, T., Takata, K., Elsayed, A. A., Satou, A., Takahashi, E., Kinoshita, T., & Nakamura, S. (2015) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000323 · Cited by 72
Self-citationIG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
Wagener, R., López, C., Kleinheinz, K., Bausinger, J., Aukema, S., Nagel, I., Toprak, U. H., Seufert, J., Altmüller, J., Thiele, H., et al. (2018) · Blood · doi:10.1182/blood-2018-03-842088 · Cited by 72
Self-citationEBV-positive diffuse large B-cell lymphoma in young adults: is this a distinct disease entity?
Hong, J. Y., Yoon, D. H., Suh, C. H., Huh, J., Do, I.-G., Sohn, I., Jo, J., Jung, S., Hong, M. E., Yoon, H., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu556 · Cited by 71
Self-citationBasha, B. M., Bryant, S. C., Rech, K. L., Feldman, A. L., Vrana, J. A., Shi, M., Reed, K. A., & King, R. L. (2019) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001315 · Cited by 70
Self-citationLandsburg, D. J., Falkiewicz, M. K., Petrich, A. M., Chu, B. A., Behdad, A., Li, S., Medeiros, L. J., Cassaday, R. D., Reddy, N. M., Bast, M. A., et al. (2016) · British Journal of Haematology · doi:10.1111/bjh.14282 · Cited by 69
Self-citationPanel Sequencing Shows Recurrent Genetic FAS Alterations in Primary Cutaneous Marginal Zone Lymphoma
Maurus, K., Appenzeller, S., Roth, S., Kuper, J., Rost, S., Meierjohann, S., Arampatzi, P., Goebeler, M., Rosenwald, A., Geissinger, E., et al. (2018) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2018.02.015 · Cited by 67
Liquid biopsy for the identification of intravascular large B-cell lymphoma
Suehara, Y., Sakata‐Yanagimoto, M., Hattori, K., Nanmoku, T., Itoh, T., Kaji, D., Yamamoto, G., Abe, Y., Narita, K., Takeuchi, M., et al. (2018) · Haematologica · doi:10.3324/haematol.2017.178830 · Cited by 67
Recurrent MSCE116K mutations in ALK-negative anaplastic large cell lymphoma
Luchtel, R. A., Zimmermann, M. T., Hu, G., Dasari, S., Jiang, M., Oishi, N., Jacobs, H. K., Zeng, Y., Hundal, T., Rech, K. L., et al. (2019) · Blood · doi:10.1182/blood.2019000626 · Cited by 66
Self-citationMantle Cell Lymphoma With MYC Rearrangement: A Report of 17 Patients
Hu, Z., Medeiros, L. J., Chen, Z., Chen, W., Li, S., Konoplev, S. N., Lu, X. Y., Pham, L. V., Young, K. H., Wang, W., et al. (2016) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000000758 · Cited by 60
Koh, J., Jang, I., Mun, S., Lee, C., Cha, H. J., Oh, Y., Kim, J., Han, J. H., Paik, J. H., Cho, J., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021004562 · Cited by 60
Chromosome 20 loss is characteristic of breast implant–associated anaplastic large cell lymphoma
Vries, G. T. L.-D., de Boer, M., van Dijk, E., Stathi, P., Hijmering, N. J., Roemer, M. G. M., Mendeville, M., Miedema, D. M., de Boer, J. P., Rakhorst, H. A., et al. (2020) · Blood · doi:10.1182/blood.2020005372 · Cited by 58
Xian, R. R., Xie, Y., Haley, L. M., Yonescu, R., Pallavajjala, A., Pittaluga, S., Jaffe, E. S., Duffield, A. S., McCall, C. M., Gheith, S. M. F., et al. (2020) · Blood Cancer Journal · doi:10.1038/s41408-020-0335-0 · Cited by 57
Self-citationBomben, R., Rossi, F. M., Vit, F., Bittolo, T., D’Agaro, T., Zucchetto, A., Tissino, E., Pozzo, F., Vendramini, E., Degan, M., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-21-0701 · Cited by 57
Self-citationRodríguez, M., Alonso‐Alonso, R., Tomás‐Roca, L., Rodríguez-Pinilla, S. M., Manso, R., Cereceda, L., Borregón, J., Villaescusa, T., Córdoba, R., Sánchez‐Beato, M., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2021005171 · Cited by 56
Self-citationMiyaoka, M., Kikuti, Y. Y., Carreras, J., Ikoma, H., Hiraiwa, S., Ichiki, A., Kojima, M., Ando, K., Yokose, T., Sakai, R., et al. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.134 · Cited by 54
Self-citationZhou, X. A., Yang, J., Ringbloom, K. G., Martínez‐Escala, M. E., Stevenson, K. E., Wenzel, A. T., Fantini, D., Martin, H. K., Moy, A. P., Morgan, E. A., et al. (2021) · Blood Advances · doi:10.1182/bloodadvances.2020002469 · Cited by 54
Self-citationSYK expression in monomorphic epitheliotropic intestinal T-cell lymphoma
Mutzbauer, G., Maurus, K., Buszello, C., Pischimarov, J., Roth, S., Rosenwald, A., Chott, A., & Geissinger, E. (2017) · Modern Pathology · doi:10.1038/modpathol.2017.145 · Cited by 52
Hartmann, S., & Eichenauer, D. A. (2019) · Pathology · doi:10.1016/j.pathol.2019.10.003 · Cited by 52
Pittaluga, S., Nicolae, A., Wright, G. W., Melani, C. J., Roschewski, M. J., Steinberg, S. M., Huang, D., Staudt, L. M., Jaffe, E. S., & Wilson, W. H. (2020) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-20-0009 · Cited by 52
Self-citationThe molecular landscape and other distinctive features of primary cutaneous follicle center lymphoma
Barasch, N., Liu, Y., Ho, J., Bailey, N. G., Aggarwal, N., Cook, J. R., & Swerdlow, S. H. (2020) · Human Pathology · doi:10.1016/j.humpath.2020.09.014 · Cited by 52
Self-citationOishi, N., Hundal, T., Phillips, J. L., Dasari, S., Hu, G., Viswanatha, D. S., He, R. L., Mai, M., Jacobs, H. K., Ahmed, N., et al. (2020) · Haematologica · doi:10.3324/haematol.2019.245860 · Cited by 50
Self-citationCollinge, B. J., Ben‐Neriah, S., Chong, L. C., Boyle, M., Jiang, A., Miyata‐Takata, T., Farinha, P., Craig, J. W., Slack, G. W., Ennishi, D., et al. (2020) · Blood · doi:10.1182/blood.2020007193 · Cited by 50
Self-citationImmunophenotypic Spectrum and Genomic Landscape of Refractory Celiac Disease Type II
Soderquist, C. R., Lewis, S. K., Gru, A. A., Vlad, G., Williams, E. S., Hsiao, S. J., MANSUKHANI, M. M., Park, D. C., Bacchi, C. E., Alobeid, B., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001658 · Cited by 49
Künstner, A., Witte, H. M., Riedl, J., Bernard, V., Stölting, S., Merz, H., Olschewski, V., Peter, W., Ketzer, J., Busch, Y., et al. (2021) · Haematologica · doi:10.3324/haematol.2021.279631 · Cited by 46
Evrard, S., Péricart, S., Grand, D., Amara, N., Escudié, F., Gilhodes, J., Bories, P., Traverse‐Glehen, A., Dubois, R., Brousset, P., et al. (2018) · Haematologica · doi:10.3324/haematol.2018.198572 · Cited by 45
Self-citationFitzpatrick, M. J., Massoth, L. R., Marcus, C. B., Vergilio, J., Severson, E. A., Duncan, D. L., Ramkissoon, S. H., Hasserjian, R. P., Kim, A. S., Sohani, A. R., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001708 · Cited by 45
Laurent, C., Adélaı̈de, J., Guillé, A., Tesson, B. M., Gat, E., Evrard, S., Escudié, F., Syrykh, C., Canioni, D., Fabiani, B., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001726 · Cited by 40
Self-citationBhavsar, S., Liu, Y.-C., Gibson, S. E., Moore, E. M., & Swerdlow, S. H. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001750 · Cited by 39
Self-citationTzankov, A., Leu, N., Muenst, S. E., Juškevičius, D., Klingbiel, D., Mamot, C., & Dirnhofer, S. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0168-7 · Cited by 38
Self-citationMolecular background delineates outcome of double protein expressor diffuse large B-cell lymphoma
Meriranta, L., Pasanen, A., Alkodsi, A., Haukka, J. K., Karjalainen‐Lindsberg, M., & Leppä, S. (2020) · Blood Advances · doi:10.1182/bloodadvances.2020001727 · Cited by 38
Monomorphic Epitheliotropic Intestinal T-Cell Lymphoma in Asia Frequently Shows SETD2 Alterations
Tomita, S., Kikuti, Y. Y., Carreras, J., Sakai, R., Takata, K., Yoshino, T., Beà, S., Campo, E., Missiaglia, E., Bouilly, J., et al. (2020) · Cancers · doi:10.3390/cancers12123539 · Cited by 36
Self-citationSchinke, C., Hoering, A., Wang, H., Carlton, V. E. H., Thanandrarajan, S., Deshpande, S., Patel, P., Molnar, G., Susanibar-Adaniya, S. P., Mohan, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.165217 · Cited by 34
Nodal EBV+ cytotoxic T-cell lymphoma: A literature review based on the 2017 WHO classification
Kato, S. X., Yamashita, D., & Nakamura, S. (2020) · Journal of the Japan Society of the Reticuloendothelial System · doi:10.3960/jslrt.20001 · Cited by 34
Self-citationSlonim, L. B., Ma, S., Behdad, A., & Chen, Q. (2020) · British Journal of Haematology · doi:10.1111/bjh.16948 · Cited by 32
The diagnostic and therapeutic challenges of Grade 3B follicular lymphoma
Barraclough, A., Bishton, M. J., Cheah, C. Y., Villa, D. R., & Hawkes, E. A. (2021) · British Journal of Haematology · doi:10.1111/bjh.17404 · Cited by 29
Cited by
Global burden of hematologic malignancies and evolution patterns over the past 30 years
Zhang, N., Wu, J., Wang, Q., Liang, Y., Li, X., Chen, G., Ma, L., Liu, X., & Zhou, F. (2023) · Blood Cancer Journal · doi:10.1038/s41408-023-00853-3 · Cited by 432
Metadata
- Authors
- Campo, E., Jaffe, E. S., Cook, J. R., Quintanilla-Martinez, L., Swerdlow, S. H., Anderson, K. C., Brousset, P., Cerroni, L., de Leval, L., Dirnhofer, S., Dogan, A., Feldman, A. L., Fend, F., Friedberg, J. W., Gaulard, P., Ghia, P., Horwitz, S. M., King, R. L., Salles, G., San-Miguel, J., Seymour, J. F., Treon, S. P., Vose, J. M., Zucca, E., Advani, R., Ansell, S., Au, W.-Y., Barrionuevo, C., Bergsagel, L., Chan, W. C., Cohen, J. I., d’Amore, F., Davies, A., Falini, B., Ghobrial, I. M., Goodlad, J. R., Gribben, J. G., Hsi, E. D., Kahl, B. S., Kim, W.-S., Kumar, S., LaCasce, A. S., Laurent, C., Lenz, G., Leonard, J. P., Link, M. P., Lopez-Guillermo, A., Mateos, M. V., Macintyre, E., Melnick, A. M., Morschhauser, F., Nakamura, S., Narbaitz, M., Pavlovsky, A., Pileri, S. A., Piris, M., Pro, B., Rajkumar, V., Rosen, S. T., Sander, B., Sehn, L., Shipp, M. A., Smith, S. M., Staudt, L. M., Thieblemont, C., Tousseyn, T., Wilson, W. H., Yoshino, T., Zinzani, P.-L., Dreyling, M., Scott, D. W., Winter, J. N., & Zelenetz, A. D.
- Venue
- Blood
- Publisher
- American Society of Hematology
- Published
- 2022-09-15
- Volume
- 140
- Issue
- 11
- Pages
- 1229-1253
- ISSN
- 0006-4971 (ISSN-L)
- 1528-0020
- OpenAlex
- W4281625438
- Cited by
- 1,608
- References
- 211
- FWCI
- 179.81
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.